Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Upregulation
100%
Cytokine
100%
Cell Activation
100%
Cell Adhesion Proteins
100%
Mediator
50%
Vascularization
50%
Coronary Artery
50%
Inflammation Response
50%
Lysine
50%
Histone
50%
Keyphrases
Inflammation
100%
Nuclear factor-κB
100%
S-adenosylhomocysteine
100%
Enhancer of Zeste Homolog 2 (EZH2)
100%
Adhesion Molecules
18%
Endothelial Activation
18%
Knockdown
9%
Endothelial Cells
9%
Lysine
9%
Dominant Negative
9%
Vasculature
9%
Adverse Effects
9%
Potent Inhibitor
9%
Endothelial Dysfunction
9%
Inflammatory Response
9%
New Targets
9%
Inflammatory Mediators
9%
Histone H3
9%
Induced Activation
9%
Negative Type
9%
Methyltransferase
9%
Atherogenesis
9%
S-adenosylmethionine Decarboxylase
9%
Trimethylation
9%
Induced Endothelial Cells
9%
Non-canonical
9%
NF-κB Pathway
9%
Epigenetic Regulators
9%
Medicine and Dentistry
Endothelial Cell
100%
Cell Activation
100%
S Adenosylhomocysteine
100%
Upregulation
18%
Cytokine
18%
Methyltransferase
18%
Cell Adhesion Proteins
18%
Coronary Artery
9%
Vascularity
9%
Endothelial Dysfunction
9%
Serositis
9%
S-Adenosyl Methionine
9%
Histone H3
9%
Lysine
9%
Inflammatory Mediator
9%
Adverse Effect
9%
Atherogenesis
9%
Biochemistry, Genetics and Molecular Biology
Cell Activation
100%
EZH2
100%
S-Adenosyl-L-Homocysteine
100%
Cytokine
18%
Upregulation
18%
Methyltransferase
18%
Cell Adhesion Proteins
18%
Epigenetics
9%
S-Adenosyl Methionine
9%
Vascularization
9%
Mediator
9%
Histone H3
9%
Lysine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
S Adenosylhomocysteine
100%
Cytokine
18%
Methyltransferase
18%
Cell Adhesion Proteins
18%
Lysine
9%
S-Adenosyl Methionine
9%
Histone H3
9%
Endothelial Dysfunction
9%
Atherogenesis
9%
Neuroscience
S-Adenosyl-L-Homocysteine
100%
Cell Activation
100%
Methyltransferase
18%
Cell Adhesion Proteins
18%
Lysine
9%
Adverse Effect
9%
Histone H3
9%
S Adenosylmethionine
9%